Here is the abstract from my research:
Osteoarthritis, otherwise known as OA, is a common and painful disorder characterized by the degeneration of diarthrodial joints. Over time, the weakened tissue is less able to withstand mechanical loading, to the point that even normal activities produce abnormal wear and damage. One of the approaches to treating OA is the design of an engineered tissue, through decellularization, that reproduces the functional properties of healthy tissue while reducing the chances of tissue rejection. However, these decellularizing methods can be considered harsh, removing essential proteins needed for the subsequent cell seeding processes. One way to reduce this degradation is through crosslinking. This research aimed to develop a functional construct (made out of porcine articular cartilage) that will withstand the biochemical degradation from decellularization by using the crosslinking agent, genipin. Ultimately, I hypothesize that increasing concentrations of genipin will prevent the biochemical degradation of the porcine articular cartilage as evidenced by the GAG assay. A dose-dependent and time-dependent study of genipin was done after the specimens were decellularized for 48 hours in 2% SDS. For the 15 min study and the 30 min study, specimens were incubated in 0, 5, and 10 mM genipin. Afterward, a glycosaminoglycans (GAG) assay was completed to quantify the GAG levels to determine the biochemical integrity of the tissue. In order to identify if there is a significant difference in GAG preservation levels between the different time and dosage intervals of genipin, a Hotelling’s T-squared (T²) test will be performed. A statistically significant difference will occur if the p-value in GAG levels is ≤ 0.05, rejecting the null hypothesis that genipin does not contribute to lessening biochemical degradation.
Key Words: tissue engineering, decellularization, genipin, GAG assay, articular cartilage